Venus Medtech wraps up Keystone Heart merger
China-based transcatheter heart valve company Venus Medtech (Hangzhou) has completed its merger with medical device company Keystone Heart.
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
27 Dec 18
China-based transcatheter heart valve company Venus Medtech (Hangzhou) has completed its merger with medical device company Keystone Heart.
20 Dec 18
Ochsner Health System has announced a new partnership with Geneva Health Solutions (GHS) to bring innovation to Louisiana…
13 Dec 18
A jury in the US District Court for the District of Delaware had determined that the Boston Scientific…
13 Dec 18
WhiteSwell has secured $30m in series B funding round, led by RA Capital Management and an InCube Ventures…
04 Dec 18
JenaValve Technology has received approval from the US Food and Drug Administration (FDA) for expanding its investigational device…
04 Dec 18
Medtronic stated that the first patient has been treated in the Terminate AF trial, which will assess simultaneous…
04 Dec 18
Conformal Medical, an early stage medical device company engaged in the development of devices to prevent stroke in…
04 Dec 18
Atlantic Health System's Morristown Medical Center has announced that its cardiac team carried out the world's first transcatheter…
30 Nov 18
Micro Interventional Devices (MID) has announced continued enrollment of patients for its Study of Transcatheter Tricuspid Annular Repair…
30 Nov 18
Biosense Webster, part of Johnson & Johnson Medical Devices, has commenced the Stellar US investigational device exemption (IDE)…